Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New tumor suppressor gene linked to cancer predisposition

21.04.2005


Scientists have identified a new gene that appears to be linked to a small but significant percentage of familial cancer cases – as well as seemingly randomly occurring malignancies.



The finding has scientists re-examining commonly held beliefs about the nature and frequency of genetic mutation as a cause of cancer. Familial cancer, in contrast to inherited cancer, is defined as multiple cases of cancer in one family that cannot be accounted for by classic rules of inheritance.

The findings are published in the April 21 issue of the New England Journal of Medicine.


“The findings suggest that a lot of cancer we once thought of as random may not be so random after all,” says George Calin, an adjunct assistant professor and research scientist in molecular virology, immunology and medical genetics and the first author of the study. He added that the findings hold important diagnostic and economic implications, as well.

Most geneticists believe that less than 5 percent of cancer is inherited, primarily through mutation in a relatively small number of well-known genes. Calin says that this new gene, however, dubbed ARLTS1, (ADP – Ribosylation Factor-Like Tumor Suppressor 1) can also increase a person’s chances of developing cancer, but only a little.

“ARLTS1 is one of an emerging set of genes whose effects are subtle, but which still play an important and predictable role in the development of cancer in some people.”

Researchers have known for years that a handful of well-known genes (like BRCA1 and BRCA2, for example) can, when mutated, dramatically increase a person’s risk of developing cancer. This “second tier” of genes, on the other hand, may heighten the risk of cancer for a much larger group of patients, says Carlo Croce, director of the Human Cancer Genetics Program at Ohio State and senior author of the study.

“Detecting alterations in such genes may more clearly predict who is predisposed to getting cancer, and who is not,” he adds.

Calin and Croce, both members of Ohio State’s Comprehensive Cancer Center, working with an international team of colleagues, had long suspected that a particular stretch of DNA on chromosome 13 – known as a rich source of mutations linked to various malignancies – might be the location of other genes important in carcinogenesis. Multiple tests with a portion of that DNA yielded ARLTS1 as a specific new gene.

ARLTS1 belongs to the Ras superfamily of genes that regulates cell growth. Most of the genes in that family are oncogenes, meaning that when activated, they cause cells to grow out of control. ARLTS1, on the other hand, is a tumor suppressor gene – a gene that normally helps the body identify and destroy suspicious-looking cells before they undergo malignant transformation and spread. When ARLTS1 is altered, it loses that ability, giving tumors a chance to establish themselves and grow.

To determine the extent to which ARLTS1 appears in various populations, researchers compared tumor tissue or blood samples from 325 patients with different forms of familial or sporadic cases of cancer to the blood of 475 healthy donors or patients with diseases other than cancer. The families, from the United States, France, Italy and Romania, included patients with chronic myeloid leukemia, or thyroid, colorectal, breast, lung or early stage pancreatic cancer.

Through multiple experimental and computational methods, researchers found that mutated ARLTS1 is three times more likely to be present in patients with familial cancers, and two times more likely to be present in random cases of cancer, than it is in the general population.

Calin says normal ARLTS1 activity can be compromised through deletion, mutation or alteration by a chemical change called methylation, adding that defective ARLTS1 also leads to inhibition of apoptosis, or normal cell death.

“We feel this discovery is significant on several levels. First, it adds one more player to the growing number of genes that are known to be active in the development of some forms of cancer,” says Croce.

“We also see this same gene mutated in small number of cancers that we once thought were randomly occurring in the general population. This is important for patients because one day in the near future, we will be able to incorporate a test for this gene – and others – into a simple screening tool that may reveal the extent to which a person is at risk for developing cancer.”

Calin says such tests could mean earlier detection of disease “which is not only good health, but good business.”

Grants from the National Cancer Institute, the Italian Ministry of Public Health and the Italian Association for Cancer Research supported the project.

Researchers from many cancer centers contributed to the study, including scientists from the Kimmel Cancer Center, Fox Chase Cancer Center; University of California at San Diego; Dana Farber Institute; University of Ferrara, Italy; Aarhus University, Denmark; Fundeni Hospital, Romania; University La Sapienza, Italy; Pasteur Institute, Paris; University of Catanzaro, Italy; Kyushu University, Japan; and Instituto Dermopatico dell’Immacolata, Italy.

Michelle Gailiun | EurekAlert!
Further information:
http://www.osu.edu

More articles from Life Sciences:

nachricht Navigational view of the brain thanks to powerful X-rays
18.10.2017 | Georgia Institute of Technology

nachricht Separating methane and CO2 will become more efficient
18.10.2017 | KU Leuven

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>